Cargando…
Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents
We report 2 cases of Whipple disease (WD), previously diagnosed as seronegative polyarthritis and treated for several years with immunosuppressive agents, accordingly. Both cases had been treated over years with cDMARDs and bDMARDs. The first patient was a 48-year-old male, who developed a life-thre...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815603/ https://www.ncbi.nlm.nih.gov/pubmed/31737398 http://dx.doi.org/10.1155/2019/3410468 |
_version_ | 1783463221597831168 |
---|---|
author | Quartuccio, Luca Giovannini, Ivan Pizzolitto, Stefano Scarpa, Maurizio De Vita, Salvatore |
author_facet | Quartuccio, Luca Giovannini, Ivan Pizzolitto, Stefano Scarpa, Maurizio De Vita, Salvatore |
author_sort | Quartuccio, Luca |
collection | PubMed |
description | We report 2 cases of Whipple disease (WD), previously diagnosed as seronegative polyarthritis and treated for several years with immunosuppressive agents, accordingly. Both cases had been treated over years with cDMARDs and bDMARDs. The first patient was a 48-year-old male, who developed a life-threatening disease characterized by fever, significant weight loss, and bloody diarrhoea, supported with RBC transfusions. The second patient was a 55-year-old man, presenting with arthritis, fever, serositis, lymphadenopathy, thoracic rash, and systemic inflammation; at the beginning he was diagnosed as adult onset Still's disease. He was treated with steroids and antitumour necrosis factor agents, but showed no improvement. Both patients were eventually treated with antimicrobial therapy for WD with dramatic improvement and no clinical relapse in 6 months. This paper reviews the literature on WD mimicking chronic inflammatory arthritis. WD may lead to chronic seronegative arthritis that might often be misrecognized. Importantly, patients treated with bDMARDs and glucocorticoids might develop a life-threatening disease. Therefore, WD should be suspected and excluded in patients showing resistance or frequent recurrence of chronic arthritis, if seronegative, under treatment with bDMARDs, especially in the presence of new, unexpected sign and/or symptoms. |
format | Online Article Text |
id | pubmed-6815603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-68156032019-11-17 Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents Quartuccio, Luca Giovannini, Ivan Pizzolitto, Stefano Scarpa, Maurizio De Vita, Salvatore Case Rep Rheumatol Case Report We report 2 cases of Whipple disease (WD), previously diagnosed as seronegative polyarthritis and treated for several years with immunosuppressive agents, accordingly. Both cases had been treated over years with cDMARDs and bDMARDs. The first patient was a 48-year-old male, who developed a life-threatening disease characterized by fever, significant weight loss, and bloody diarrhoea, supported with RBC transfusions. The second patient was a 55-year-old man, presenting with arthritis, fever, serositis, lymphadenopathy, thoracic rash, and systemic inflammation; at the beginning he was diagnosed as adult onset Still's disease. He was treated with steroids and antitumour necrosis factor agents, but showed no improvement. Both patients were eventually treated with antimicrobial therapy for WD with dramatic improvement and no clinical relapse in 6 months. This paper reviews the literature on WD mimicking chronic inflammatory arthritis. WD may lead to chronic seronegative arthritis that might often be misrecognized. Importantly, patients treated with bDMARDs and glucocorticoids might develop a life-threatening disease. Therefore, WD should be suspected and excluded in patients showing resistance or frequent recurrence of chronic arthritis, if seronegative, under treatment with bDMARDs, especially in the presence of new, unexpected sign and/or symptoms. Hindawi 2019-10-13 /pmc/articles/PMC6815603/ /pubmed/31737398 http://dx.doi.org/10.1155/2019/3410468 Text en Copyright © 2019 Luca Quartuccio et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Quartuccio, Luca Giovannini, Ivan Pizzolitto, Stefano Scarpa, Maurizio De Vita, Salvatore Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents |
title | Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents |
title_full | Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents |
title_fullStr | Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents |
title_full_unstemmed | Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents |
title_short | Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents |
title_sort | seronegative arthritis and whipple disease: risk of misdiagnosis in the era of biologic agents |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815603/ https://www.ncbi.nlm.nih.gov/pubmed/31737398 http://dx.doi.org/10.1155/2019/3410468 |
work_keys_str_mv | AT quartuccioluca seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents AT giovanniniivan seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents AT pizzolittostefano seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents AT scarpamaurizio seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents AT devitasalvatore seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents |